De toegang tot informatie op deze website is uitsluitend voorbehouden aan professionele beleggers in België. Belangrijk: lees a.u.b. de onderstaande informatie. Deze bevat informatie over wet- en regelgeving die van toepassing is op de status van onze onderneming en het gebruik van deze website, en over alle beleggingen in onze producten die in deze website ter sprake komen. Opgelet! U moet deze algemene voorwaarden aanvaarden alvorens verder te kunnen gaan. Copyright 2021 Nordea Investment Funds S.A. – alle rechten voorbehouden.
We wijzen u erop dat u de bepalingen over ons privacybeleid en het gebruik van cookies dient te lezen en goed te keuren voordat u toegang krijgt tot onze websites.
Het volledige privacy- en cookiebeleid vindt u via de onderstaande link.
De toegang tot informatie op deze website is uitsluitend voorbehouden aan beleggers in België. Belangrijk: lees a.u.b. de onderstaande informatie. Deze bevat informatie over wet- en regelgeving die van toepassing is op de status van onze onderneming en het gebruik van deze website, en over alle beleggingen in onze producten die in deze website ter sprake komen. Opgelet! U moet deze algemene voorwaarden aanvaarden alvorens verder te kunnen gaan. Copyright 2021 Nordea Investment Funds S.A. – alle rechten voorbehouden.
We wijzen u erop dat u de bepalingen over ons privacybeleid en het gebruik van cookies dient te lezen en goed te keuren voordat u toegang krijgt tot onze websites.
Het volledige privacy- en cookiebeleid vindt u via de onderstaande link.
Het gewenste artikel of de gewenste pagina is niet beschikbaar voor uw domein, geselecteerde taal en/of uw beleggerscategorie.
Ga naar de homepageApril 2020
Nordea 1, SICAV
Société d’Investissement à Capital Variable
Registered Office: 562, rue de Neudorf, L-2220 Luxembourg
R.C.S. Luxembourg B 31442
INFORMATION UPDATE
IMPORTANT INFORMATION: |
In view of the COVID-19 outbreak, Nordea 2, SICAV is taking precautionary measures to limit the exposure for its shareholders and other stakeholders. Given the outbreak of the COVID-19 and the related limitations on travel and large gatherings, this year’s annual general meeting will be held without a physical presence, as permitted by Luxembourg law. In view thereof, arrangements have been made to provide shareholders with the opportunity to vote by proxy voting in electronic form (please refer to the practicalities herein). |
The shareholders of Nordea 1, SICAV (the “Company”) are hereby informed that due to the exceptional COVID-19 situation and in compliance with article 1.(1) of the Grand Ducal regulation of 20 March 2020 introducing measures concerning meetings in companies and other legal entities, no physical attendance of the annual general meeting of shareholders to be held on 23 April 2020 at 10:00 CET (the “Meeting”) will be possible.
Shareholders are herewith provided with the possibility to express their vote by means of proxy voting submitted in electronic form. Proxies issued in their former form and already received before 14 April 2020 remain valid.
In order to vote at the Meeting, shareholders are invited to send the duly completed and signed proxy form attached hereto to arrive no later than 20 April 2020, 17:00 CET by e-mail to [email protected]
Luxembourg, 14 April 2020
IMPORTANT
Shareholders are invited to send a duly completed and signed proxy form to arrive no later than 20 April 2020, 17:00 CET by e-mail to [email protected]
POWER OF ATTORNEY
I, the undersigned
«Name»
«Address1»
«Address2»
«Address3»
«Account ID XXXXXXXX»
owner of ______________ shares of Nordea 1, SICAV (the “Company”), having its registered office in 562, rue de Neudorf, L-2220 Luxembourg hereby appoint
Jeremie Houet, Head of Corporate Law of Nordea Investment Funds S.A. (Chairperson)
as my proxy holder to represent me and vote in my name and on my behalf at the annual general meeting of shareholders of the Company on 23 April 2020 at 10:00 CET (the “Meeting”), with the following resolutions to be adopted:
For |
Against |
Abstention |
||
1 |
Submission of the reports of the board of directors of the Company (the “Board of Directors” and each member individually a “Director”) and of the Company’s approved statutory auditor for the fiscal year ended 31 December 2019 (the “Auditor”); |
|
|
|
2 |
Approval of the balance sheet and the profit and loss statement for the fiscal year ended 31 December 2019; |
|
|
|
3 |
Dividend distribution; |
|
|
|
4 |
Allocation of net results; |
|
|
|
5 |
Discharge to the Directors and the Auditor in respect of the carrying out of their duties during the financial year ended 31 December 2019; |
|
|
|
6 |
Appointment of Directors and the approved statutory Auditor of the Company; |
|
|
|
7 |
Approval of Directors’ fees; |
|
|
|
The proxy holder shall have the broadest powers whatsoever, including the power of substitution, to represent and bind the undersigned at the said Meeting or any subsequent meeting having the same agenda, to take part in all deliberations and to vote in my name and on my behalf any resolution, to sign any document and generally to do anything necessary or useful in relation with the contemplated agenda.
Date________________________ Signature(s)________________________________________